
Midatech Pharma plc MTP
Quarterly report 2025-Q4
added 05-14-2026
Midatech Pharma plc DSO Ratio 2011-2026 | MTP
Annual DSO Ratio Midatech Pharma plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 204 | 981 | - | - | - | - |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 981 | 204 | 593 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
2.94 K | - | 5743.5 % | $ 69.7 M | ||
|
Coherus BioSciences
CHRS
|
559 | $ 1.57 | -3.68 % | $ 184 M | ||
|
Happiness Biotech Group Limited
HAPP
|
29 | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
70.9 | $ 16.87 | -2.49 % | $ 789 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
21.2 | $ 7.47 | -4.6 % | $ 205 M | ||
|
Eton Pharmaceuticals
ETON
|
39.1 | $ 30.26 | 1.0 % | $ 814 M | ||
|
Exelixis
EXEL
|
43.4 | $ 50.13 | -1.9 % | $ 13.6 B | ||
|
Fortress Biotech
FBIO
|
115 | $ 2.41 | 4.78 % | $ 67.2 M | ||
|
AbCellera Biologics
ABCL
|
173 | $ 4.09 | -7.05 % | $ 1.22 B | ||
|
Autolus Therapeutics plc
AUTL
|
58.2 | $ 1.63 | 2.52 % | $ 434 M | ||
|
Gilead Sciences
GILD
|
57.8 | $ 129.58 | -1.88 % | $ 161 B | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 3.36 | -3.72 % | $ 5.53 M | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | $ 3.12 | - | $ 649 M | ||
|
Genmab A/S
GMAB
|
97.9 | $ 26.54 | -1.34 % | $ 1.72 B | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
106 | $ 21.32 | -1.16 % | $ 2.71 B | ||
|
Fennec Pharmaceuticals
FENC
|
148 | $ 9.75 | 5.52 % | $ 279 M |